Alembic Pharma | APLLTD | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
7,493
9,998
13,681
6,254
3,546
Cash flow Operating Act...
Cash flow Operating Activities
8,1204,49114,6345,5247,240
Investments in PPE
Investments in PPE
-6,539-6,727-6,595-4,256-4,434
Cash flow Investing Act...
Net cash used for Investment Activities
-7,556-7,316-8,388-3,720-4,476
Dividend Paid
Dividend Paid
9093,26002,7521,966
Cash flow Financing Act...
Net cash provided by Financing Activities
5901,549-5,974-2,174-2,620
Cash at beginning of period
Cash at beginning of period
8371,991718981611
Cash at end of period
Cash at end of period
1,991718981611755
Free Cash Flow
Free Cash Flow
1,580
-2,235
8,039
1,267
2,805